Con: The routine use of aprotinin during pediatric cardiac surgery is not a benefit
Authors:
- Chandra RamamoorthyCRChandra Ramamoorthy
- 1 December 1999
- journal article
- editorial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 13 (6) , 785-788
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Cost-Benefit and Efficacy of Aprotinin Compared with ε-Aminocaproic Acid in Patients Having Repeated Cardiac OperationsAnesthesiology, 1997
- The Efficacy of Tranexamic Acid Versus Placebo in Decreasing Blood Loss in Pediatric Patients Undergoing Repeat Cardiac SurgeryAnesthesia & Analgesia, 1997
- Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac OperationsThe Annals of Thoracic Surgery, 1997
- Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operationsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Mediastinal Bleeding After Cardiopulmonary Bypass in Pediatric PatientsThe Annals of Thoracic Surgery, 1996
- The Efficacy and Cost of Aprotinin in Children Undergoing Reoperative Open Heart SurgeryAnesthesia & Analgesia, 1996
- Aprotinin improves outcome of single-ventricle palliationThe Annals of Thoracic Surgery, 1996
- Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in childrenThe Annals of Thoracic Surgery, 1996
- RETRACTED: Aprotinin in pediatric cardiac operations: Platelet function, blood loss, and use of homologous bloodThe Annals of Thoracic Surgery, 1993